Coriaria intermedia
Coriaria intermedia
Coriaria intermedia is a plant traditionally not well-documented in any specific medical or folk traditions. Scientific research has identified seven compounds from this plant, some of which potentially inhibit α-glucosidase and 15-lipoxygenase, though the evidence for these effects is currently limited. Additionally, a novel species of bacteria, Streptomyces coriariae sp. nov., was isolated from root nodules of Coriaria intermedia, suggesting potential microbial interactions with the plant. The study also identified novel Frankia cluster-2 strains associated with Coriaria species in New Zealand and Patagonia, indicating early divergence within these species. No major safety issues or drug interactions have been recorded for this plant to date.
- Best evidence
- D
- Cautions
- —
Informational only. Traditional use does not mean proven effectiveness. Evidence and safety vary — check the cited sources.
What the science says
- Seven compounds from Coriaria intermedia were identified, with one (corilagin) showing potential for both diabetes and inflammation.
- Strain CMB-FB represents a novel species, Streptomyces coriariae sp. nov., isolated from Coriaria intermedia root nodules.
- The study identified novel Frankia cluster-2 strains associated with Coriaria species in New Zealand and Patagonia, suggesting early divergence of these species.
- The study found evidence of a clear split within Frankia cluster-2, suggesting divergence in Gondwana and separate dispersal routes.
Frequently asked questions
What is Coriaria intermedia?
Coriaria intermedia (Coriaria intermedia) is a plant documented in FolkKB's traditional-medicine reference, drawn from sourced literature and cross-checked against the evidence.
What does the scientific evidence say about Coriaria intermedia?
4 sourced findings are recorded for Coriaria intermedia; the strongest carries evidence grade D. For example: Seven compounds from Coriaria intermedia were identified, with one (corilagin) showing potential for both diabetes and inflammation.
How strong is the evidence for Coriaria intermedia?
The strongest finding for Coriaria intermedia carries evidence grade D — preliminary or traditional. Grades run A (strongest) to D (preliminary or traditional).
Is Coriaria intermedia safe? What are the side effects?
No major safety issues are recorded for Coriaria intermedia in our sources, but the data may be incomplete. Consult a qualified professional before use.
Does Coriaria intermedia interact with medications?
No drug interactions are recorded for Coriaria intermedia in our sources. This does not rule them out — check with a pharmacist.
Is Coriaria intermedia a proven treatment?
No. FolkKB is informational only. Traditional use and early findings are not proof of efficacy or safety — consult a qualified professional and never self-treat.
Sources
- T2 A tale of two lineages: how the strains of the earliest divergent symbiotic Frankia clade spread over the world. literature abstract metadata
- T2 Streptomyces coriariae sp. nov., a novel streptomycete isolated from actinorhizal nodules of Coriaria intermedia. literature abstract metadata
- T2 Genome analysis and biogeographic distribution of the earliest divergent Frankia clade in the southern hemisphere. literature abstract metadata
- T2 Anti-diabetic and anti-inflammatory bioactive hits from Coriaria intermedia Matsum. stem and Dracontomelon dao (Blanco) Merr. & Rolfe bark through bioassay-guided fractionation and liquid chromatography-tandem mass spectrometry. literature abstract metadata